BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30127633)

  • 21. Do you know this syndrome? Xeroderma pigmentosum (XP).
    Viana Fde O; Cavaleiro LH; Carneiro CM; Bittencourt Mde J; Barros RS; Fonseca DM
    An Bras Dermatol; 2011; 86(5):1029. PubMed ID: 22147055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation.
    Itoh T; Linn S; Kamide R; Tokushige H; Katori N; Hosaka Y; Yamaizumi M
    J Invest Dermatol; 2000 Dec; 115(6):981-5. PubMed ID: 11121129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and photobiological characteristics of xeroderma pigmentosum complementation group F: a review of cases from Japan.
    Yamamura K; Ichihashi M; Hiramoto T; Ogoshi M; Nishioka K; Fujiwara Y
    Br J Dermatol; 1989 Oct; 121(4):471-80. PubMed ID: 2696553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis of xeroderma pigmentosum.
    Copeland NE; Hanke CW; Michalak JA
    Dermatol Surg; 1997 Jun; 23(6):447-55. PubMed ID: 9217796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nephroblastoma and xeroderma pigmentosum: A rare association].
    Lahlimi F; Harif M; Elhoudzi J
    Arch Pediatr; 2016 Jan; 23(1):75-7. PubMed ID: 26655364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Melanoma in xeroderma pigmentosum: 12 cases].
    Fazaa B; Zghal M; Bailly C; Zeglaoui F; Goucha S; Mokhtar I; Kharfi M; Ezzine N; Kamoun MR
    Ann Dermatol Venereol; 2001 Apr; 128(4):503-6. PubMed ID: 11395647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facial resurfacing with a monoblock full-thickness skin graft after multiple malignant melanomas excision in xeroderma pigmentosum.
    Ozmen S; Uygur S; Eryilmaz T; Ak B
    J Craniofac Surg; 2012 Sep; 23(5):1542-3. PubMed ID: 22976654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xeroderma pigmentosum: beyond skin cancer.
    Lichon V; Khachemoune A
    J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premalignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum.
    Paridaens AD; McCartney AC; Hungerford JL
    Br J Ophthalmol; 1992 Feb; 76(2):120-2. PubMed ID: 1739708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xeroderma pigmentosum in Ghanaians: a report of three cases and review of literature.
    Adu EJ
    West Afr J Med; 2014; 33(1):82-5. PubMed ID: 24872274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome.
    Broughton BC; Thompson AF; Harcourt SA; Vermeulen W; Hoeijmakers JH; Botta E; Stefanini M; King MD; Weber CA; Cole J
    Am J Hum Genet; 1995 Jan; 56(1):167-74. PubMed ID: 7825573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
    Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
    J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C.
    Legerski R; Peterson C
    Nature; 1992 Sep; 359(6390):70-3. PubMed ID: 1522891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
    Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
    J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sunlight-induced cancer: some new aspects and implications of the xeroderma pigmentosum model.
    Lehmann AR; Bridges BA
    Br J Dermatol; 1990 Apr; 122 Suppl 35():115-9. PubMed ID: 2186779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhalation anesthesia in a patient with xeroderma pigmentosum: a case report.
    Hajijafari M; Ziloochi MH; Fazel MR
    Anesth Pain Med; 2014 Aug; 4(3):e17880. PubMed ID: 25289371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Xeroderma pigmentosum with normal excision-repair capacity and decreased U-V tolerance (author's transl)].
    Sandhofer M; Tuschl H; Kovac R; Altmann H
    Wien Klin Wochenschr; 1976 Apr; 88(9):296-9. PubMed ID: 973389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xeroderma pigmentosum: a glimpse into nucleotide excision repair, genetic instability, and cancer.
    Dworaczek H; Xiao W
    Crit Rev Oncog; 2007 Nov; 13(2):159-77. PubMed ID: 18197791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.